Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden
· Delayed Price · Currency is SEK 298.20
-3.60 (-1.19%)
Jun 13, 2025, 5:29 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 9.39 billion as of June 13, 2025. Its market cap has decreased by -23.05% in one year.
Market Cap
9.39B
Enterprise Value
9.11B
Revenue
854.98M
Ranking
n/a
PE Ratio
68.90
Stock Price
298.20
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 9.39B, an increase of 2,427.13%. That is a compound annual growth rate of 28.99%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 100.70B |
| Sectra AB | 61.62B |
| Getinge AB | 51.14B |
| Asker Healthcare Group AB | 40.22B |
| Camurus AB | 36.77B |
| Medicover AB | 36.46B |
| AddLife AB | 23.97B |
| Vimian Group AB | 21.81B |